SEATTLE , Aug. 18, 2022 /PRNewswire/ -- According to Coherent Market Insights, the global bone glue market is estimated to be valued at US$ 2,332.0 million in 2022 and is expected to exhibit a CAGR of 5.9 % during the forecast period (2022-2030).
Key Trends and Analysis of the Global Bone Glue Market:
Major players operating in market are focusing on adopting growth strategies such as distribution agreement, which is expected to drive the market growth over the forecast period. For instance, in July 2021 , Celularity Inc., a clinical-stage biotechnology company, and Arthrex, Inc., a global invasive orthopedic technology company, announced that the companies have entered into an exclusive partnership to distribute and commercialize Celularity's biomaterial products for orthopedic surgery and sports medicine. Under the terms of the partnership, Celularity will provide Arthrex with exclusive commercial distribution rights for orthopedic surgery and sports medicine and will continue to be responsible for product manufacturing and supply.
Market players are focused on growth strategies such as development of new technologies. For instance, in August 2020 , LaunchPad Medical, Inc. announced that the company has rebranded its name, RevBio, the objective of developing its revolutionary Tetranite bone adhesive biomaterial platform. The company's musculoskeletal focus in developing products for both dental and orthopedic applications, where its patented biomaterial could significantly improve the standard of care for patients and offer a less invasive treatment option for doctors.
Request Sample Copy of this Report @ https://www.coherentmarketinsights.com/insight/request-sample/242
Market players are focused on growth strategies such as development of new bone glue. This in turn is expected to drive growth of the global bone glue market. For instance, in July 2019, the development of orthopedic Strontium (Sr)-dicalcium silicate bone cements with in situ Sr substitution and homogeneous Sr distribution was announced by the researchers from Hunan University of Science and Technology. For orthopedic applications, the osteogenesis potential of dicalcium silicate bone cement containing Sr was increased. Sr-C2S bone cements showed great potential in promoting osteogenesis in a preliminary study on the effects of Sr-C2S (Sr-incorporated dicalcium silicate) bone cements on proliferation.
Among product type, the synthetic bone glue segment is expected to account for a major revenue share by 2030 owing to increasing use of synthetic polymers. For instance, on 29 March 2022 , MDPI, an open access publishing academic community, published a report on biodegradable and biocompatible adhesives for the effective stabilization, repair and regeneration of bone, which stated that polyurethane-based synthetic polymers have also been proposed as bone bio adhesives due to their high bonding strength and ability to achieve adhesion in a wet environment.
Among region, North America is expected to hold a dominant position in the global bone glue market over the forecast period, owing to increasing rate of prevalence in the spinal cord injury. For instance, in 2020, National Spinal Cord Injury Stastical Center, published as report which estimated the annual incidence of spinal cord injury (SCI) is approximately 54 cases per one million people in the U.S., or about 17,810 new SCI cases each year. New SCI cases do not include those who die at of the incident that caused the SCI.
Key players operating in the global bone glue market include Cryolife, Luna Innovations Incorporated, Johnson and Johnson, Cohera Medical Inc, Tissuemed Ltd., Integra Lifesciences Corporation, Baxter International Inc., B.Braun Melsungen AG, DENTSPLY SIRONA Inc., Chemence Medical Inc., LaunchPad Medical, and C.R. Bard Inc.
Request for Customization @ https://www.coherentmarketinsights.com/insight/request-customization/242
Global Bone Glue Market, By Product type:
Global Bone Glue Market, By Therapeutic Application:
Global Bone Glue Market, By End User:
Global Bone Glue Market, By Region
Buy this Complete Report Now @ https://www.coherentmarketinsights.com/insight/buy-now/242
Find related trending report below:
Europe Gelatin and Bone Glue Market, By Product Type (Gelatin (Acidic Pretreatment, Alkali Pretreatment), Bone Glues (Synthetic Bone Glues, Natural Bone Glues)), By Application (Arthroplasty, Sports Injury, Spine Surgery, Trauma, Others), By End User (Hospital, Specialty Clinics, Ambulatory Surgical Centers), and By Country (Germany , U.K., France , Italy , Spain , Russia , Rest of Europe ) - Size, Share, Outlook, and Opportunity Analysis, 2020 - 2027
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India , having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan . Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us: Mr. Shah Senior Client Partner – Business Development Coherent Market Insights Phone: US: +1-206-701-6702 UK: +44-020-8133-4027 Japan : +81-050-5539-1737 India : +91-848-285-0837 Email: sales@coherentmarketinsights.com Website: https://www.coherentmarketinsights.com Follow Us: LinkedIn | Twitter
Logo: https://mma.prnewswire.com/media/902389/Coherent_Market_Insights_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/global-bone-glue-market-to-surpass-us-3-687-8-million-by-2030--coherent-market-insights-301608412.html
In the world of stock legends, George Soros stands out. While his political activities have been a lightning rod for controversy, no one can doubt his financial acumen. After all, he’s the ‘man who broke the Bank of England,’ and made a billion dollars in one day when he shorted the Pound Sterling back in 1992. His hedge fund, Soros Fund Management, showed three decades of sustained gains, averaging 30% annual returns through the year 2000. During this time, and today in the management of his pe
Markets correspondent Jared Blikre takes a look at the declining pricing for cryptocurrencies bitcoin and ethereum as the FDIC issue letters to five crypto companies.
Yahoo Finance Live co-anchor Seana Smith looks at several trending stocks moving in after-hours trading.
A 20-year-old USC student has made a $110 million profit from trading meme stock favorite Bed Bath & Beyond, following a frenzy in Wednesday’s trading session.
The stock rose as much as 272% but is up about 175% as of 1:25 p.m. ET. The tech stock's gain came on the day of its initial public offering (IPO). Given the way the stock is soaring, the market apparently thinks the IPO was underpriced.
Jake Freeman cashed out his 6% stake in the meme stock after it exploded on Tuesday.
Back up the EV on shares of General Motors, says this one analyst.
Strategists at Citi Research say the current bear-market rally is in line with the length of an average bear-market bounce, and sentiments improved as much as it typically does. These signs suggest a possible end soon.
Shares of StoneCo (NASDAQ: STNE), a cloud-based technology platform, plummeted Friday morning after the company reported its second-quarter results, which disappointed investors, and announced yet another shift to its management team. The company reported non-GAAP (adjusted) earnings of 0.25 Brazilian reals (equivalent to $0.05), which was an increase from a loss of 0.48 reals in the year-ago quarter, but was below Wall Street's consensus estimate of about 0.57 reals, or $0.11 per share. StoneCo's revenue in the quarter was 2.3 billion reals (about $442 million), 5% higher than the company's guidance, and up 275% from the year-ago quarter.
It's no wonder Altria's (NYSE: MO) stock has lost more than a fifth of its value in just a couple of months. Marketing partner Philip Morris International (NYSE: PM) is getting cold feet on working with Altria to sell its IQOS heated tobacco device while also just acquiring the leading competitor to Altria's own smokeless tobacco products. At the same time, the federal government all but obliterated Altria's $13 billion investment in Juul Labs, the one-time electronic-cigarette leader.
(Bloomberg) -- Billionaire Ryan Cohen pocketed a $68.1 million profit from the sale of his stake in Bed Bath & Beyond Inc., scoring a 56% gain on an investment he held for roughly seven months.Most Read from BloombergUS Mortgage Lenders Are Starting to Go BrokeMueller Memo Advising Barr on Trump Findings Is Ordered ReleasedStocks Slide as Short-Sellers Cash In on Fedspeak: Markets WrapXi and Putin to Attend G-20 Summit in Indonesia, Jokowi SaysApple Targets Sept. 7 for iPhone 14 Launch in Flurry
The stock market might be at a crossroads once again. In recent weeks, we’ve seen some solid gains, mostly across the board, as a rally has taken hold and moderated year-to-date losses on the major indexes. But is this rally running out of steam? Taking the bearish view of the current environment is Morgan Stanley’s chief US equity strategist Mike Wilson. He sees the gains right now as a bear market rally, and believes that markets will likely turn down again in the longer term. Laying out his p
The market rally is retreating as the 10-year yields runs higher, toward 3%. Warren Buffett stock Occidental Petroleum surged Friday.
CEO Mary Barra previously said the automaker plans to double its annual revenue by 2030 shifting its focus to electric and autonomous vehicles, connected services and new businesses.
For investors looking to maximize their wealth by the time they retire, the following pair of beaten-down businesses that possess strong growth capabilities are a worthwhile place to start. Freelance marketplace operator Fiverr (NYSE: FVRR) was a pandemic-lockdown superstar. Although Fiverr's stock price is down 65% in 2022 and off 82% from its all-time high, the freelance shop is still growing, albeit at a slower rate as SMBs became more cautious due to rampant inflation and rising energy costs and interest rates.
Nvidia stock has recovered a bit after a revenue warning, but the chip bellwether remains firmly entrenched below its 200-day moving average.
After a major investor sold his holdings in the struggling retailer and caused its stock price to plummet, Vanguard Group's holdings in the company lost 50% of its value from just two days ago.
Retail traders were quick to flock to the side of Chewy Inc (NYSE: CHWY) founder and GameStop Corp (NYSE: GME) chair Ryan Cohen when he purchased a stake in Bed Bath & Beyond Inc (NASDAQ: BBBY) in March. Less than six months later, Cohen has filed intent to sell his stake in the embattled retailer and accusations are flying. One institutional investor has suggested that Cohen used retail investors to pump the stock for his own benefit. What To Know: Luke Lloyd, wealth advisor and investment stra
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
In this article, we discuss 10 Cathie Wood stocks to buy before the bull run starts. If you want to see more stocks preferred by Cathie Wood to load up on before the bull run begins, click 5 Cathie Wood Stocks to Buy Before the Bull Run Starts. Cathie Wood, the founder and CIO of […]